Categories: Capital Markets
Greenberg Traurig represent Enlivex Therapeutics Ltd. (“Enlivex”, NASDAQ: ENLV), which recently announced the successful completion of a $51.3 million offering of its Ordinary Shares. Leading the transaction on behalf of GT are Bob Grossman, Chair of Greenberg Traurig’s Israel Practice and senior M&A and financing attorney at the firm’s Miami office, together with Drew Altman, Chair of the Miami Corporate Practice with considerable experience in Israeli transactions, and Win Rutherfurd, Miami Corporate attorney. The GT team in Miami, together with support from Aaron Katz, Corporate Tel Aviv attorney, represented Enlivex on its 2019 merger through which the company became a public company in the United States. Additionally, the GT team in Miami represented the company on two registered direct offerings, one ATM offering and one underwritten offering during the past 12 months.
GT – Greenberg Traurig P.A.
